Kiplinger

Stock Market Today: Gilead Gives Stocks a Booster Shot

Gilead Sciences (GILD, +2.2%) once again helped inject a little life into stocks Friday with the help of its coronavirus treatment remdesivir.

The major indices appeared poised for losses in early trading amid another record surge in U.S. COVID-19 cases, as well as yesterday's comments from Treasury

You’re reading a preview, subscribe to read more.

More from Kiplinger

Kiplinger4 min read
This New Sustainable ETF’s Pitch? Give Back Profits.
Feel like society and the environment are beginning to break down? There’s an ETF for that. Newday Impact’s Sustainable Development Goals ETF (SDGS) delivers a growth-oriented product that promotes dual impact, promising to advocate for environmental
Kiplinger3 min read
Cryptocurrency: Stay In? Get Out? How to Decide?
Warren Buffett is famous for saying “Only when the tide goes out do you discover who's been swimming naked.” If you invested in cybercoins, the news has not been good lately. Are you wearing your bathing suit?  What to do?  Is time to take your profi
Kiplinger4 min read
Got Crypto? The IRS Really Wants to Know
The 2022 crypto price crash understandably has some investors concerned. But for those of you who haven’t run for the hills, it’s worth knowing that cryptocurrency currently has the attention of not only the Biden administration, and Congress, but th

Related Books & Audiobooks